{
  "input": {
    "mode": "build_counterchain",
    "query": {
      "entity": "Atypical haemolytic uraemic syndrome",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_eculizumab",
          "name": "Eculizumab"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_ravulizumab",
          "name": "Ravulizumab"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_avacopan",
          "name": "Avacopan"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_furosemide",
          "name": "Furosemide"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_amlodipine",
          "name": "Amlodipine"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_steroids",
          "name": "Steroids"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_angiotensin_ii_receptor_blockers",
          "name": "Angiotensin II receptor blockers"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_rasburicase",
          "name": "Rasburicase"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_caplacizumab",
          "name": "Caplacizumab"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_sirolimus",
          "name": "Sirolimus"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_defibrotide",
          "name": "Defibrotide"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_corticosteroids",
          "name": "Corticosteroids"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 4
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_ot_eculizumab",
          "type": "Target",
          "label": "Eculizumab Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_eculizumab",
          "type": "Pathway",
          "label": "Eculizumab Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_eculizumab",
          "type": "Phenotype",
          "label": "Eculizumab Adverse Phenotype",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_ravulizumab",
          "type": "Target",
          "label": "Ravulizumab Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_ravulizumab",
          "type": "Pathway",
          "label": "Ravulizumab Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_ravulizumab",
          "type": "Phenotype",
          "label": "Ravulizumab Adverse Phenotype",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_avacopan",
          "type": "Target",
          "label": "Avacopan Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_avacopan",
          "type": "Pathway",
          "label": "Avacopan Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_avacopan",
          "type": "Phenotype",
          "label": "Avacopan Adverse Phenotype",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_furosemide",
          "type": "Target",
          "label": "Furosemide Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_furosemide",
          "type": "Pathway",
          "label": "Furosemide Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_furosemide",
          "type": "Phenotype",
          "label": "Furosemide Adverse Phenotype",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_eculizumab",
          "target": "n_ot_eculizumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路作用"
        },
        {
          "source": "n_ot_eculizumab",
          "target": "n_rp_eculizumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "关联的风险路径"
        },
        {
          "source": "n_rp_eculizumab",
          "target": "n_adv_eculizumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可导致不良表型"
        },
        {
          "source": "n_adv_eculizumab",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "风险影响净获益"
        },
        {
          "source": "drug_ravulizumab",
          "target": "n_ot_ravulizumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路作用"
        },
        {
          "source": "n_ot_ravulizumab",
          "target": "n_rp_ravulizumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "关联的风险路径"
        },
        {
          "source": "n_rp_ravulizumab",
          "target": "n_adv_ravulizumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可导致不良表型"
        },
        {
          "source": "n_adv_ravulizumab",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "风险影响净获益"
        },
        {
          "source": "drug_avacopan",
          "target": "n_ot_avacopan",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路作用"
        },
        {
          "source": "n_ot_avacopan",
          "target": "n_rp_avacopan",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "关联的风险路径"
        },
        {
          "source": "n_rp_avacopan",
          "target": "n_adv_avacopan",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可导致不良表型"
        },
        {
          "source": "n_adv_avacopan",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "风险影响净获益"
        },
        {
          "source": "drug_furosemide",
          "target": "n_ot_furosemide",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路作用"
        },
        {
          "source": "n_ot_furosemide",
          "target": "n_rp_furosemide",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "关联的风险路径"
        },
        {
          "source": "n_rp_furosemide",
          "target": "n_adv_furosemide",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可导致不良表型"
        },
        {
          "source": "n_adv_furosemide",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "风险影响净获益"
        }
      ],
      "conflict_hotspots": [
        {
          "topic": "Eculizumab vs Ravulizumab",
          "pro_nodes": [
            "H1",
            "H2"
          ],
          "con_nodes": [
            "n_adv_eculizumab",
            "n_adv_ravulizumab"
          ],
          "note": "存在相互竞争的疗效及风险"
        }
      ]
    },
    "counterclaims": [
      {
        "id": "K1",
        "text": "存在诱发不良事件的机制链，可能抵消疗效",
        "confidence": "medium"
      },
      {
        "id": "K2",
        "text": "疗效存在个体差异，可能受到其他因素影响",
        "confidence": "medium"
      }
    ],
    "assumptions_challenged": [
      "每种药物的疗效机制是否足够明确",
      "对抗药物产生的耐药性潜力"
    ],
    "falsification_tests": [
      "是否有大规模临床试验数据显示长期生存率改善？",
      "对于现有药物有效性的相关对照测试结果是什么？"
    ],
    "next_focus_for_pi": [
      "要求 Proponent 提供对比研究数据以支撑疗效论据",
      "评估各药物的不良反应数据以明确风险"
    ]
  }
}